Mechanistic understanding of pre-mRNA splicing requires detailed structural information on various states of the spliceosome. Here we report the cryo electron microscopy (cryo-EM) structure of the human spliceosome just before exon ligation (the C* complex) at an average resolution of 3.76 Å . The splicing factor Prp17 stabilizes the active site conformation. The step II factor Slu7 adopts an extended conformation, binds Prp8 and Cwc22, and is poised for selection of the 3 0 -splice site. Remarkably, the intron lariat traverses through a positively charged central channel of RBM22; this unusual organization suggests mechanisms of intron recruitment, confinement, and release. The protein PRKRIP1 forms a 100-Å a helix linking the distant U2 snRNP to the catalytic center. A 35-residue fragment of the ATPase/ helicase Prp22 latches onto Prp8, and the quaternary exon junction complex (EJC) recognizes upstream 5 0 -exon sequences and associates with Cwc22 and the GTPase Snu114. These structural features reveal important mechanistic insights into exon ligation.
In Brief
The first atomic structure of human spliceosome reveals important insights into exon ligation.
INTRODUCTION
Splicing of precursor messenger RNA (pre-mRNA) is carried out by the spliceosome (Wahl et al., 2009) . Each splicing cycle consists of two sequential steps of transesterification (Fica et al., 2013; Moore et al., 1993; Wahl et al., 2009 ). The first step, commonly known as branching, results in the release of the 5 0 -exon and formation of an intron lariat intermediate. The second step leads to ligation of the 5 0 -and 3 0 -exons. The highly dynamic spliceosome contains a stable core of about 20 components. Spliceosomal remodeling by the conserved DExD/H-box ATPases/helicases during each splicing cycle generates at least seven distinct states: the pre-catalytic B complex, the activated B act complex, the step I catalytically activated B* complex, the C complex, the step II catalytically activated C* complex, the postcatalytic P complex, and the ILS complex (Ohrt et al., 2013; Will and Lü hrmann, 2011) . Prp16 and Prp22 belong to DEAHbox ATPases/helicases. Prp16 catalyzes the conversion of the C to C* complex where the second-step transesterification occurs (Horowitz, 2012; Schwer and Guthrie, 1992; Warkocki et al., 2009 ). The ligated exon in the P complex is released by Prp22 (Company et al., 1991; Schwer, 2008; Schwer and Gross, 1998) , generating the ILS complex. Mechanistic understanding of pre-mRNA splicing has taken a quantum leap from recent cryo electron microscopy (cryo-EM) analyses of the yeast B act , C, C*, and ILS complexes (Fica et al., 2017; Galej et al., 2016; Hang et al., 2015; Rauhut et al., 2016; Wan et al., 2016; Yan et al., 2015; Yan et al., 2016a Yan et al., , 2017 . The spliceosome is proven to be a protein-directed metalloribozyme (Gordon et al., 2000; Hang et al., 2015; Keating et al., 2010; Sontheimer et al., 1997; Steitz and Steitz, 1993; Yan et al., 2015) , and the molecular mechanism of the first-step transesterification (branching) is elucidated in atomic details. In contrast, the second-step transesterification (exon ligation) remains to be mechanistically characterized despite structural advances on the C* complex (Bertram et al., 2017; Fica et al., 2017; Yan et al., 2017) . Limited by its inherent compositional heterogeneity and conformational flexibility, the human spliceosome is yet to be captured at an atomic resolution. In this manuscript, we report the cryo-EM structure of the human C* complex at an average resolution of 3.76 Å , with the local resolution at the center of the spliceosome reaching 3.0-3.5 Å . Using a combination of de novo modeling, homology building, and structure docking, we have generated a complete atomic model for the human C* complex. The structure reveals a number of striking features that advance mechanistic understanding of the exon ligation.
RESULTS

Overall Structure of the C* Complex
To trap the C* complex, we incubated the HeLa cell nuclear extract with a synthetic MS2-tagged MINX pre-mRNA where the nucleotides AG at the 3 0 end of the 3 0 -splice site (3 0 SS) were mutated to GG. The assembled spliceosome was affinity purified, centrifuged in the presence of the crosslinking agent glutaraldehyde, and imaged on a Titan Krios microscope (Figure S1) . A total of 661,614 particles were chosen from 7,308 micrographs and sorted by three-dimensional (3D) classifications ( Figure S2 ). Reconstruction of 100,085 particles yielded an EM density map of the human spliceosome at an average resolution of 3.76 Å on the basis of the FSC value 0.143 (Figures S2 and S3; Tables S1 and S2 ). The EM map quality in the peripheral regions of the spliceosome was further improved by the application of soft masks and additional 3D classification ( Figure S4 ).
The local resolutions reach 3.0-3.5 Å for about 20 components in the core of the spliceosome, allowing identification of amino acid side chains and assignment of RNA nucleotides (Figures S5 and S6) . Although the quality of the EM map is progressively lower away from the core (Table S2) , it still allows atomic modeling in the surrounding regions and docking of known X-ray structures in the periphery. The final atomic model of the human C* complex contains 14,496 residues from 46 proteins and 380 RNA nucleotides, which amount to approximately 1.7 mega-Daltons ( Figure 1A ; Tables S1 and S2). Of the modeled residues, 12,030 have side chains, and the rest were built as poly-Ala. 321 nucleotides are assigned to U2, U5, and U6 snRNAs. 59 nucleotides are attributed to the intron lariat intermediate and the 5 0 -exon. The overall organization and the active site conformation of the human C* complex are very similar to those reported in the 5.9-Å structure (Bertram et al., 2017) . The much-improved resolution allows us to identify six additional spliceosomal proteins that play crucial roles in exon ligation. These proteins include the ATPase/helicase Brr2, the step II factor Slu7, the double- (C* complex) preceding exon ligation at an average resolution of 3.76 Å . Two views are shown. The proteins and RNA elements are color coded and tabulated below. The structure shown here includes 46 proteins, three snRNAs (U2, U5, and U6), a free 5 0 -exon, and an intron lariat, with a combined molecular weight of approximately 1.7 MDa. (B) The overall RNA map in the human C* complex. Base-pairing interactions among the three snRNAs and pre-mRNA are shown. Canonical Watson-Crick and non-canonical base-pairing interactions are identified by solid lines and black dots, respectively. All structural images were created using PyMol (DeLano, 2002) . See also Figures S1-S5 , Tables S1 and S2. stranded RNA-binding protein PRKRIP1 (Yin et al., 2003) , and three components of the EJC (MAGOH, Y14, and MLN51). Importantly, we were able to continuously trace the polypeptide chains of the step II splicing factor Prp17 and the NineTeen Complex-related (NTR) protein RBM22, each playing a key role in pre-mRNA splicing. Furthermore, there are numerous fine structural features that may bear functional implications.
The RNA Elements and the Active Site On the basis of the EM density maps (Figure S6) and information on the yeast C* complex (Fica et al., 2017; Yan et al., 2017) , we modeled 140 nucleotides (nt) for U2 snRNA (nt 1-47, 54-94, and 97-184) , 84 for U5 snRNA (nt 8-71 and 85-104), 97 for U6 snRNA (nt 1-97), 18 for free 5 0 -exon, and 41 for the intron lariat (Figures 1B and 2A) . Both the overall structure and the overall conformation of the RNA elements are similar to those in the yeast C* complex (Fica et al., 2017; Yan et al., 2017) . Four nucleotides at the 3 0 end of the free 5 0 -exon form a duplex with loop I of U5 snRNA, whereas the lariat junction is anchored through duplex formation between the 5 0 -splice site (5 0 SS) and U6 snRNA and between the branch site (BS) and U2 snRNA ( Figure 1B) .
All five metal ions in the yeast C* complex (Fica et al., 2017; Yan et al., 2017) are preserved and similarly coordinated in the human C* complex. M1 stabilizes the leaving group in the branching reaction and activates the nucleophile during exon ligation (Fica et al., 2013) . In the human C* complex, M1 is coordinated by the phosphates of G72 and U74 from U6 snRNA and the 3 0 -OH at the 3 0 end of the 5 0 -exon ( Figure 2B , left panel). M2 activates the nucleophile in the branching reaction and stabilizes the leaving group during exon ligation. M2 is bound by the phosphates of three nucleotides from U6 snRNA: A53, G54, and U74 ( Figure 2B , right panel). In addition to the three structural metals, an additional metal ion stabilizes a tight turn of the RNA sequences at the edge of the internal stem loop (ISL); this metal is absent in the yeast C* complex (Fica et al., 2017; Yan et al., 2017) (Figure 2C ).
Compared to the yeast C* complex (Fica et al., 2017; Yan et al., 2017) , a notable difference is formation of a considerably longer duplex between U6 snRNA and the 5 0 SS and ensuing sequences of the intron in the human C* complex ( Figures 1B and  2D ). The EM density in this region allow unambiguous identification of the duplex but is insufficient for atomic modeling of the base-pairing interactions ( Figure S7A ). Although the ISL is perfectly aligned between the human and yeast C* complexes, the U6 snRNA sequences upstream of the ACAGA box exhibit quite distinct local conformations due to formation of the extended duplex in the human C* complex ( Figure 2E ). The intron sequences downstream of the 5 0 SS in the human C* complex are separated away from those in the yeast by up to 40 Å . Remarkably, the EM density for a large proportion of the intron sequences, both downstream and upstream of the lariat junction, is clearly visible (Figures S7B and S7C ). This organization likely places the disordered portion of the lariat in contact with the two RecA domains of the RNA helicase Aquarius (De et al., 2015; Hirose et al., 2006) (Figures S7D and S7E ).
The
Step II Factors Slu7 and Prp17 The human step II factor Slu7 contains 586 residues and is predicted to be intrinsically disordered due to a high content (77%) of polar and charged amino acids (Chua and Reed, 1999) . The fine quality of the EM density map allows identification of two large segments of Slu7: residues 62-196 and 265-371 (Table  S2 ). Slu7 and the step II splicing factor Prp17 are placed on two opposing sides of the catalytic center ( Figure 3A ). The free 3 0 end of the intron lariat is directed toward Slu7, placing the disordered pyrimidine-rich sequences in a solvent channel. This organization positions the 3 0 SS and 3 0 -exon on the same side of the catalytic center as Slu7, consistent with the observation that Slu7 is directly involved in the selection of the 3 0 SS (Chua and Reed, 1999; Frank and Guthrie, 1992; Guthrie, 1995, 1996) .
The N-terminal segment of Slu7 (residues 62-196) resembles a tripod and mainly interacts with Prp8 (Hegele et al., 2012) (Figures 3B and 3C ). The first leg of the tripod (residues 62-94) consists of two short a helices and an extended intervening loop; it interacts with the Linker domain of Prp8 and the MA3 domain of the splicing factor Cwc22 ( Figures 3B and 3D) . Notably, the structurally resolved N-terminal residue-His62 of Slu7-is only about 20 Å away from the free 3 0 end of the intron lariat (Figure 3D) , and 11 of the 61 preceding disordered residues are Lys and Arg, which may bind the negatively charged pre-mRNA sequences. The second leg (residues 95-158) mostly associates with the N domain of Prp8 and contains a C2HC-type zinc finger (Cys120, Cys123, His128, and Cys133), which directly contacts the MIF4G domain of Cwc22 ( Figure 3E ). The third leg (residues 159-196) of the tripod mainly interacts with the endonuclease domain of Prp8 and to a lesser extent the Linker and the N domain ( Figure 3E ). The N-terminal segment of Slu7 is located close to the 5 0 -exon and likely stabilizes its binding to the spliceosome, thus facilitating the second step of transesterification (Chua and Reed, 1999; Zhang and Schwer, 1997) .
The C-terminal segment of Slu7, comprising four a helices interspersed by extended loops, has two subdomains. One subdomain (residues 265-318) is wedged at the interface between the endonuclease domain and the highly mobile RNaseH-like domain of Prp8, making close interactions with residues from both domains ( Figures 3F and 3G ). On one hand, Arg290 of Slu7 donates three hydrogen bonds (H bonds) to the RNaseHlike domain, two to the side chain of Glu1873 and one to the carbonyl oxygen of Ile1882 ( Figure 3G ). On the other hand, Arg266 and Tyr274 of Slu7 each makes an H bond to Asp1592 of the endonuclease domain. The other subdomain binds the RNaseH-like domain of Prp8 and is in close proximity of the Jab1/MPN domain of Prp8 ( Figures 3B and 3C ), which forms a stable complex with Brr2 throughout the two steps of transesterification.
Previous structures of the spliceosome only allow identification of the C-terminal WD40 repeats of the step II splicing factor Prp17, which plays a key role in the second transesterification step (Vijayraghavan et al., 1989) . In the human C* complex, Prp17 is continuously modeled from residue 83 to the C terminus (Table S2) . Remarkably, the N-terminal portion of Prp17 adopts a highly extended conformation, reaching out as far as 100 Å to interact with a number of protein components and U6 snRNA ( Figure S8A ). These interactions likely safeguard the integrity of the catalytic center.
The fully extended N-terminal fragment (residues 83-117) of Prp17 sequentially binds PPIL1 (Cyp1 in S. pombe) and RBM22 before contributing a b strand to the anti-parallel b-hairpin of SKIP (Prp45 in yeast) ( Figure S8B ). The ensuing fragment (residues 118-175) interacts with U5-40K (Cwf17 in S. pombe), SKIP, RBM22, an N-terminal a helix of Prp8, and the 5 0 end sequences of U6 snRNA. The middle portion of Prp17 (residues 176-230) closely associates with G10 (Bud31 in yeast) and RBM22 and hovers above the extended duplex between the intron and U6 snRNA ( Figure S8C ). The C-terminal half of Prp17 (residues 231-578) forms a seven-bladed b-propeller, with its top face (convention of [Wall et al., 1995] ) binding an a helix at the N terminus of Cdc5 (residues 165-194) ( Figure S8D ). The rim of the top face contacts Syf3. The Prp17 b-propeller, together with the associating fragments of Cdc5 and Syf3, is wedged between the BS/U2 duplex and the 5 0 SS/U6 duplex, consistent with a prior study (Xu et al., 1998) . Apparently, these interactions stabilize the conformation of the splicing active site (Umen and Guthrie, 1995) .
Intron Confinement by RBM22
As previously noted (Rasche et al., 2012) , the sequences of human RBM22 correspond to those from two distinct yeast proteins: Cwc2 and Ecm2 ( Figure S9 ). RBM22 comprises an N-terminal zinc-binding domain and a C-terminal RRM domain. The N-terminal domain (residues 19-221) mainly contains a globular fold, which is homologous to that of the yeast Ecm2 and binds two zinc ions ( Figures 4A and S9 ). This domain also contains an extended loop (residues 162-186) that bears sequence homology to that of the yeast Cwc2 and binds a zinc ion. The C-terminal RRM domain (residues 222-303) shares sequence homology with that of the yeast Cwc2 ( Figure S9 ). RBM22 is strategically positioned in the spliceosome, making direct contacts to the ISL of U6 snRNA and binding the intron lariat, and organizes at least five protein components ( Figures 4A and 4B ). Specifically, the C-terminal domain binds PPIL1 and SKIP, whereas the N-terminal domain interacts with the N-terminal loop sequences of Cdc5, G10, SKIP, Prp17, and U6 snRNA and the intron sequences ( Figure 4B ).
Most unexpectedly, the RNA sequences downstream of the 5 0 SS traverse through a central channel within the N-terminal domain of RBM22 ( Figures 4A and 4B ). The channel is highly enriched by positively charged amino acids ( Figure 4C ), which stabilize intron binding through direct interactions. Because these RNA sequences are part of the intron lariat and covalently linked to the downstream BS sequences, the intron lariat is in fact locked within a folded RBM22 protein. Apparently, the binding of the linear pre-mRNA, which presumably occurs just prior to the formation of the B act complex, and the release of the intron lariat, which proceeds in the transition of the P to ILS complex, require partial unfolding of RBM22. Analysis of the structural organization reveals that such a process likely requires the RBM22 fragment 185-221 to separate from the N-terminal domain ( Figure 4D ).
PRKRIP1 and the ATPase/Helicase Prp22
The precise role of the protein PRKRIP1 in pre-mRNA splicing remains enigmatic. A large fragment of PRKRIP1 (residues 51-142) is unambiguously identified and occupies a prominent location in the human C* complex ( Figure 5A ). This fragment is positively charged and essential for double-stranded RNA binding (Yin et al., 2003) . PRKRIP1 consists of a fully extended N-terminal loop (residues 51-75) and an 18-turn a helix (residues 76-142) that spans 100 Å ( Figure 5A ). PRKRIP1 directly links the catalytic center with the U2 snRNP at the periphery of the spliceosome. The N-terminal portion of the a helix and its preceding loop sequences are inserted into a cavity that is formed by the RNaseH-like domain of Prp8, the U2/BS duplex, and the WD40 repeats of Prp17 ( Figure 5B ). The C-terminal portion of PRKRIP1 binds the U2 snRNP (Huttlin et al., 2015) , with the C-terminal five turns of the a helix placed in the major groove of the U2 snRNA duplex. The location of PRKRIP1 in the spliceosome and its interactions with other essential spliceosomal components suggest an important role in the splicing reaction.
The ATPase/helicase Prp22 directly interacts with Prp8. A 35-residue fragment of Prp22 (residues 393-427) is bound in a large cavity formed between the RT Fingers/Palm and the Linker domain of Prp8 ( Figure 5C ). There are a mixture of specific H bonds and van der Waals interactions at the interface ( Figure 5D ). Importantly, the amino acids of Prp22 that directly interact with Prp8, exemplified by Trp400 and Gln404, are invariant between yeast and human ( Figure 5E ). After exon ligation, Prp22 is thought to bind and pull the 3 0 -sequences of the ligated exon, releasing the exon from the P complex (Company et al., 1991; Schwer and Gross, 1998) . In our structure, the RNA sequences downstream of the BS including the mutated 3 0 SS and the 3 0 -exon are disordered. The distance between the 3 0 end nucleotide of the intron lariat and the RNA binding site of Prp22 spans approximately 100 Å ( Figure 5C ), which requires a minimal of 15 nucleotides in their fully extended conformation. This analysis is consistent with the observation that shortened 3 0 -exon inhibited the release of the ligated exon from the P complex (Schwer, 2008) .
Exon Junction Complex
As a molecular shepherd of mRNA, the exon junction complex (EJC) is assembled and deposited onto exons during premRNA splicing (Boehm and Gehring, 2016; Tange et al., 2004) . All four components of the EJC-eIF4AIII, MAGOH, Y14, and MLN51-are identified in the human C* complex ( Figure 6A ). The ATPdependent RNA helicase eIF4AIII, previously identified in the 5.9-Å structure of the human C* complex (Bertram et al., 2017) , binds a stretch of six contiguous RNA nucleotides and simultaneously interacts with MAGOH, MLN51, and the splicing factor Cwc22. The ATP-binding side of eIF4AIII closely associates with the N-terminal MIF4G domain of Cwc22 (Alexandrov et al., 2012; Barbosa et al., 2012; Steckelberg et al., 2012) , and the EJC is connected to the core of the spliceosome mainly through an interface between eIF4AIII and the GTPase Snu114 ( Figures 6A and 6B) . The 5 0 end nucleotide (GÀ 12 ) of the 5 0 -exon is separated by a distance of about 33 Å from the 3 0 end nucleotide of the exon sequences bound in eIF4AIII. This distance requires a minimum of five RNA nucleotides ( Figure 6B ). This analysis is consistent with the fact that eIF4AIII binds the RNA sequences 20-24 nucleotides upstream of the exon-exon junctions (Le Hir et al., 2000) .
The RecA1 domain of eIF4AIII directly interacts with Snu114 ( Figure 6C, upper panel) . The structural elements of RecA1 that bind Snu114 in the human C* complex partially overlap with those that associate with the MLN51 fragment 216-246 in the isolated EJC (Andersen et al., 2006; Bono et al., 2006) (Figure 6C , lower panels). To avoid steric hindrance, the MLN51 fragment 216-246 must be dissociated from the RecA1 domain of eIF4AIII upon recruitment of the EJC into the spliceosome. A large lobe of weak EM density next to the EJC is likely to be attributable to the S/R-rich regions of the splicing factor SRm300 (Cwc21 in yeast) ( Figure 6D ). The S/R-rich sequences may interact with the exon sequences upstream of those bound by the EJC.
The other three EJC proteins only interact with components within the EJC complex. The structure of MAGOH exhibits an a/b fold, with its six-stranded anti-parallel b sheet capped on side by two of its three a helices and a few structural elements from eIF4AIII ( Figure 6A ). The protein Y14 also adopts an a/b fold, with its curved, five-stranded b sheet stacking in parallel with the two long a helices of MAGOH. The heterodimer between MAGOH and Y14 is thought to inhibit the ATPase activity of eIF4AIII, thus increasing the RNA-binding affinity of EJC (Gehring et al., 2005) . One of the two a helices of Y14 also directly contacts the MIF4G domain of Cwc22. A small fragment (residues 170-194) of the protein MLN51, which stimulates the ATPase/helicase activity of eIF4AIII (Noble and Song, 2007) , interacts with eIF4AIII near the 5 0 end of the bound exon RNA element.
Comparison with the Yeast C* Complex
The structurally resolved human C* complex differs from the S. cerevisiae complex in several ways. Nine proteins in the human complex (Aquarius, Brr2, PPIL1, PRKRIP1, U5-40K, and four components of the EJC) are absent in the S. cerevisiae complex ( Figure 7A ). Compared to that in S. cerevisiae, the step II splicing factors Slu7 and Prp17 are much better defined in the human C* complex. In fact, the knowledge on the locations of Slu7 and Prp17 in the human complex allows modeling of these proteins into the weak EM density maps of the S. cerevisiae C* complex. Curiously, however, the step II factor Prp18, which is present in the S. cerevisiae C* complex, is absent in the human complex ( Figure 7B ). The binding site for Prp18 in the S. cerevisiae C* complex is no longer preserved in the human complex. The delicate active site conformation in the human C* complex is facilitated by the WD40 repeats of Prp17, the RNaseH-like domain of Prp8, and the N-terminal portion of PRKRIP1. We suggest that Prp18 may have been dissociated from the catalytic center following its prior action in the human spliceosome. Another major difference is the substitution of Ecm2 and Cwc2 in the S. cerevisiae C* complex by RBM22 in the human complex. This change redirects the intron sequences and reorganizes the surrounding protein components (Figure 7C) . Between the two C* complexes, the relative locations of the NineTeen Complex (NTC) core are quite far away (Figure 7D ). The EJC is present only in higher eukaryotes and thus absent in the S. cerevisiae C* complex ( Figure 7E ). 
DISCUSSION
The cryo-EM reconstruction of the human C* complex, determined at an average resolution of 3.76 Å , represents the first atomic structure of the human spliceosome. The human C* complex had been structurally characterized at an average resolution of 5.9 Å (Bertram et al., 2017) , and the observed general features are confirmed by our current structure. These features include the placement of and interactions among the protein components, the three snRNA molecules (U2, U5, and U6), the intron lariat, and the 5 0 -exon. In addition, the active site conformation is generally the same between these two structures. Importantly, however, there are pronounced features in our 3.76-Å structure that are absent in the 5.9-Å structure even when both structures were low-pass filtered to 10 Å ( Figures S10A and S10B) . The considerably improved resolution and the excellent EM density map of our structure allow visualization of the detailed features of the active site, identification of six additional protein components (Brr2, PRKRIP1, Slu7, and MAGOH/Y14/MLN51 of the EJC), and determination of the previously unrecognizable structural elements of several key proteins exemplified by Prp17 and RBM22 ( Figures S10C-S10E) .
Our structure reveals a wealth of information for mechanistic understanding of pre-mRNA splicing. A portion of the intron lariat is confined inside the NTR component RBM22. All NTR components are recruited into the spliceosome during the ATP-dependent, Brr2-driven remodeling of the B complex (Wahl et al., 2009 ). The linear intron sequences downstream of the 5 0 SS are presumably delivered into the interior of RBM22 in the B-to-B act transition. It remains unclear whether RBM22 is partially unfolded to allow intron binding or RBM22 requires intron binding for correct folding. Regardless of these possibilities, the branching reaction circularizes the intron into a lariat and locks it ''permanently'' with RBM22. In yeast, the location and relative orientation of Cwc2 and Ecm2 remain unchanged in all structurally resolved spliceosomal complexes. Thus, the confinement of the intron to RBM22 in the human spliceosome should be maintained throughout both steps of the splicing reaction. Whether the Prp43-mediated release of the intron lariat also results in its dissociation from RBM22 remains to be investigated. The location and structure of Slu7 are both ideally suited for a crucial role in the second step of transesterification. The structurally resolved portion of Slu7 tightly associates with Prp8 while making some contacts to the splicing factor Cwc22. In particular, the C-terminal segment of Slu7 interacts with the RNaseH-like domain of Prp8, which is known to frequently associate with a mobile RNA element (Wan et al., 2016) . Importantly, the disordered portions of Slu7 (residues 1-61, 197-264, and 372-586) are highly enriched by positively charged amino acids: 62 Arg and Lys residues in total. The unusually high content of basic residues in these sequences is likely linked to the ability of Slu7 to select the 3 0 SS of the intron. Consistent with this notion, the free 3 0 end of the intron lariat is pointed toward Slu7.
To trap the spliceosomal C* complex, we employed a synthetic MINX pre-mRNA in which the conserved penultimate nucleotide of the 3 0 SS was mutated to G. The mutant premRNA was used for in vitro assembly of the human spliceosome. Perhaps as a consequence of the mutation, the EM density maps for the RNA sequences a few nucleotides downstream of the BS are completely missing. In contrast, the endogenous S. cerevisiae C* complex, where the bound pre-mRNA molecules are endogenously derived, contains a strip of EM density at the location expected of the downstream intron sequences and the 3 0 -exon (Yan et al., 2017) . Following rigorous structural investigations of the past two years, we have made major advances into mechanistic understanding of pre-mRNA splicing by the spliceosome. Comparison of all available structures of the yeast spliceosome reveals a rigid core of approximately 20 components. These components, initially observed in the S. pombe ILS complex Yan et al., 2015) , remain structurally unchanged in the B act , C, and C* complexes (Fica et al., 2017; Galej et al., 2016; Rauhut et al., 2016; Wan et al., 2016; Yan et al., 2016a Yan et al., , 2017 . Structural comparison of these complexes allow mechanistic delineation of the branching reaction. Notably, however, mechanistic understanding of exon ligation remains preliminary, and there has been no reported atomic structure of the human spliceosome. The current study helps address these two concerns and represents an important step forward.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
AUTHOR CONTRIBUTIONS
L.I.F. made initial contributions to the project. X.Z. and J.H. purified the human C* complex and prepared the cryo-EM sample. X.Z., J.H., J.L., and C.Y. collected the EM micrographs and processed the data. C.Y. calculated the cryo-EM map and built the atomic model. All authors contributed to project discussion and structure analysis. X.Z., J.H., and C.Y. contributed to manuscript preparation. Y.S. conceived, designed, and guided the project and wrote the manuscript.
ACKNOWLEDGMENTS
We thank Jingyi Hui for providing the MINX plasmid and Robin Reed for providing the MBP-MS2 expression plasmid. We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for the cryo-EM facility and the computational facility support on the cluster of BioComputing Platform. This work was supported by funds from the National Natural Science Foundation of China (31430020 and 
CONTACT FOR REAGENT AND RESOURCE SHARDING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Yigong Shi (shi-lab@mail.tsinghua.edu.cn).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines HeLa S3 cell lines were cultured in SMM 293 TI medium without FBS at 37 C in 5% CO 2 and were used to prepare nuclear extract.
METHOD DETAILS
In vitro splicing reaction The pre-mRNA was modified in the plasmid MINX by introducing two tandem MS2 binding sites into the intron and the AG to GG mutation at the 3 0 SS. The final plasmid was named MINX-GG. The MS sites are positioned 46 nucleotides downstream of the 5 0 -splice site and 52 nucleotides upstream of the branch point sequence. As previously demonstrated (Wolf et al., 2009) , such a design ensures that the binding of the MS2 protein does not interfere with the structural integrity of the spliceosome. PCR products of the template were used to synthesize m7G(5 0 )ppp(5 0 )G-capped pre-mRNA using the method of T7 runoff transcription. Splicingactive HeLa nuclear extract was prepared according to a published protocol (Dignam et al., 1983) . A typical splicing reaction contained 15 nM MINX-GG pre-mRNA and 40% HeLa nuclear extract in a reaction buffer containing 3.5 mM MgCl 2 , 65 mM KCl, 20 mM HEPES-KOH pH 7.9, 2 mM ATP, and 20 mM creatine phosphate. To generate the C* complex, splicing reaction was incubated for 100 min at 30 C followed by RNaseH digestion and MS2-MBP affinity purification.
Affinity selection of the human C* complex A published protocol of MS2-MBP affinity purification allowed isolation of the human spliceosomal C complex assembled on mutant pre-mRNA (Bessonov et al., 2008; Jurica et al., 2002; Zhou et al., 2002) . We modified this protocol to isolate the human spliceosomal complexes. Specifically, 15 nM MINX-GG pre-mRNA was incubated with 50-fold molar excess of MS2-MBP fusion protein on ice for 1 hr. Then the MS2-MBP-bound MINX-GG pre-mRNA was mixed with the HeLa nuclear extract to initiate the splicing reaction. After 100 min, the pre-mRNA that had not been incorporated into the spliceosome was digested by endogenous RNaseH with the addition of two DNA oligonucleotides (cmd1 & cmd2) that are complementary to the upstream sequence of the 5 0 SS. The reaction was then loaded onto an amylose column for affinity selection. After extensive washing using the HS150 buffer (20 mM HEPES-KOH, 150 mM NaCl, 1.5 mM MgCl 2 , and 4% glycerol), the spliceosomal complexes were eluted by the HS150 buffer supplemented with 20 mM maltose and 2 mM ATP. Splicing reactions were performed in a volume of 50 mL or its multiples to increase the final yield of the C* complex.
Grafix crosslinking
The eluted spliceosomal complexes were loaded on a 38.6ml liner 10%-30% glycerol gradient in the G150 buffer (20 mM HEPES-KOH, 150 mM NaCl, 1.5 mM MgCl 2 ) supplemented with 0%-0.1% EM-grade glutaraldehyde (Kastner et al., 2008) . After centrifugation at 4 C for 12 hr at 25,300 rpm in a SW32 rotor (Beckman Coulter), the sample was manually fractionated into 19 fractions of about 2 mL each from top to bottom using pipettes. Total RNAs extracted from a 300-ml aliquot for each fraction were analyzed on 8% denaturing polyacrylamide gel in the presence of 8 M urea. The C* complex was included in those fractions that contain three snRNAs (U2, U5, and U6), the intron lariat intermediate, and free 5 0 -exon. Some of these fractions (#11-14) also exhibited the anticipated sedimentation coefficient of the C* complex. Fractions 11-14 were pooled and concentrated using a 100-KDa cut-off centrifugal filter unit (Amicon Ultra) to a final volume of about 500 ml. To remove the glycerol, the resulting solution was dialyzed using a 10-KDa Mini-lyzer (Pierce) in the G150 buffer for at least 5 hr. EM data acquisition and processing The spliceosomal complexes were further concentrated for EM specimen preparation. Briefly, 4 ml of the sample were loaded onto a glow-discharged copper grid coated with a thin carbon film. After waiting for 2 min for maximum absorption, grids were blotted and immersed in uranyl acetate (2%, w/v) for negative staining or rapidly plunged into liquid ethane cooled by liquid nitrogen. Cryo-EM grids were prepared using Vitrobot Mark IV (FEI Company), at 8 C and with 100 percent humidity. Micrographs were taken by an FEI Titan Krios electron microscope equipped with an energy filter operating at 300 kV with a nominal magnification of 105,000x. Images were recorded using a Gatan K2 Summit detector (Gatan Company) in the super-resolution mode, with a super-resolution pixel size of 0.669 Å . The defocus range was set from 1.0 to 2.0 mm. Each stack was exposed for 8 s with an exposing time of 0.25 s per frame, resulting in a total of 32 frames per stack. The total dose rate was about 50 e-/Å 2 for each stack. AutoEMation was used for fully automated data collection (Lei and Frank, 2005) . A total of 7,308 cryo-EM micrographs were collected. All 32 frames in each image were aligned and summed using the whole-image motion correction program MOTIONCORR and MotionCor2 (Zheng et al., 2017) , with 2-fold binned to a pixel size of 1.338 Å . The defocus value of each image was determined by Gctf (Zhang, 2016) .
Preliminary image processing
An initial dataset of 500 micrographs were first collected and processed to inspect the sample quality and composition ( Figure S2A ). 41,078 particles were semi-autopicked using the reference-based particle picking subroutine in RELION2.0 (Kimanius et al., 2016; Scheres, 2012 ). The templates for particle picking were obtained from the 2D class averages calculated from $3,000 manually picked particles. The 3D volumes of the B act , C and C* complex from S. cerevisiae and the ILS complex from S. pombe were all tested as initial references to perform 3D classification and the ILS complex from S. pombe gave the best results. The 3D volume of the ILS complex was low-pass filtered to 60 Å before using. 3D classification was directly performed without prior 2D classification using particles binned to a pixel size of 5.312 Å , yielding one good class with 25.3 percent of all particles. The other classes were judged to be bad and likely contributed by damaged particles, ice spots, contaminants, and aggregates ( Figure S2A ).
Image processing
In total, 661,614 particles were picked using the reference-based particle picking subroutine in RELION2.0 (Kimanius et al., 2016; Scheres, 2012) . A guided multi-reference classification procedure was applied in the subsequent data processing. This modified procedure had been successfully applied to other datasets including those that yielded the published structures of the B act , C and C* complexes and those that gave rise to the structure of the T4-fusion g-secretase (Sun et al., 2015; Wan et al., 2016; Yan et al., 2016a Yan et al., , 2017 . The effectiveness of this procedure has been steadily improved. All 661,614 particles were subjected to multi-reference classification using references generated from the first 500 images. To avoid the problem of discarding good particles, we simultaneously performed three parallel multi-reference 3D classifications. Particles of the best classes (22.8%, 23.2%, and 24.5% for the three parallel classifications) were merged, and the duplicated particles are removed as described before (Yan et al., 2016a (Yan et al., , 2017 . The remaining 242,219 particles, representing 36.6% of the auto-picked particles, were read back into their original images based on their refined centers as described previously Yan et al., 2016a) . One round of manual particle picking and discarding was performed, resulting in a dataset of 365,771 particles ( Figure S2B ). Three rounds of multi-reference 3D classification were further performed with 7 references applied. Three references were lowpass filtered to 15 Å , 20 Å and 40 Å , and the other four references were judged to be bad. Finally, 138,650 good particles, representing 37.9% of the particles after manual picking, were chosen, yielding an average resolution of 3.87 Å ( Figure S2B ). All micrographs were motion-corrected by MotionCor2 (Zheng et al., 2017) , which significantly improved the particle image quality. Due to the large box size of the spliceosomal particles, particle polishing (Scheres, 2014) was still considered in our data processing, resulting in slight improvement of the average resolution to 3.82 Å ( Figure S2B) . A fourth multiple-reference 3D classification was performed on the polished particles with four references low-pass filtered from 4.0 Å to 5.5 Å , and particles are converged into the first class which contains 72.2% of the input particles. Those particles improved the resolution to 3.76 Å after refinement ( Figures S2B and S3A) . The local resolutions of the map reach 3.0 Å in the central region ( Figure S3B ). Application of a soft mask on the core region of the spliceosome generated an average resolution of 3.6 Å ( Figure S3A ). For the peripheral regions, soft masks were applied and further 3D classifications were carried out in order to identify the components. (Figure S5 ).
The angular distribution of the particles used for the final reconstruction of the human C* complex is reasonable, and the refinement of the atomic coordinates did not suffer from severe overfitting ( Figure S4 ). The resulting density maps show clear features for the secondary structural elements and amino acid side chains for most protein components of the C* complex in the core region. The RNA elements and their interacting proteins are also well defined by the EM density maps ( Figure S6, S7) . Reported resolutions are calculated on the basis of the FSC 0.143 criterion, and the FSC curves were corrected for the effects of a soft mask on the FSC curve using high-resolution noise substitution (Chen et al., 2013) . Prior to visualization, all density maps were corrected for the modulation transfer function (MTF) of the detector, and then sharpened by applying a negative B-factor that was estimated using automated procedures (Rosenthal and Henderson, 2003) . Local resolution variations were estimated using ResMap (Kucukelbir et al., 2014) .
Model Building and refinement Due to a wide range of resolution limits for the various regions of the human spliceosomal C* complex, we combined de-novo model building, homologous structure modeling and rigid docking of components with known structures to generate an atomic model (Tables S2). Identification and docking of the components of the C* complex were facilitated by the structures of the ILS spliceosome from S.pombe and the C* complex from S.cerevisiae and human (Bertram et al., 2017; Fica et al., 2017; Yan et al., 2015; Yan et al., 2017) . The protein components derived from the associated PDB accession codes are summarized in Table S2 . These structures were docked into the density map using COOT (Emsley and Cowtan, 2004) and fitted into density using CHIMERA (Pettersen et al., 2004) .
The atomic models of Prp8, Snu114, U5-40K, the N-terminal half of Syf3, the Myb domain and middle region of Cdc5, and the NTCrelated (NTR) proteins except Aquarius and Prp17 were generated by CHAINSAW (Stein, 2008) and the backbone was manually adjusted using COOT (Emsley and Cowtan, 2004) . After that, automated model rebuilding was performed with RosettaCM using the adjusted model as the template and the experimental cryo-EM density as a guide (DiMaio et al., 2015; DiMaio et al., 2009; Song et al., 2013) . Then the hydrogen atoms of the generated model were removed and model building was further performed manually using COOT (Emsley and Cowtan, 2004) .
The atomic models of the Sm proteins, U2-A', U2-B,'' Aquarius, the EJC complex, and Brr2 bound to the Jab1 domain of Prp8 were directly docked into the density maps. For those protein sequences that lack a homolog structure, de novo model building was performed; this was summarized in Table S2 with a ''De novo building'' annotation. These proteins include PRKRIP1 and Slu7. The chemical properties of proteins and amino acids were considered to facilitate model building. Sequence assignment was guided mainly by bulky residues such as Phe, Tyr, Trp and Arg. Unique patterns of sequences were exploited for validation of residue assignment. The RNA sequence assignment was also greatly aided by the structure of the spliceosomal ILS complex Yan et al., 2015) . The RNA sequences were manually adjust using COOT (Emsley and Cowtan, 2004) and RCrane (Keating and Pyle, 2012) . The conformations of the RNA components were further refined using phenix.erraser (Chou et al., 2013) . On the basis of the EM density maps, six metal ions are found and five of them are located in generally the same locations as those in the yeast C* complex.
Structure refinement of the individual protein was carried out using phenix.real_space_refine application in PHENIX in real space (Adams et al., 2010) with secondary structure and geometry restraints to prevent over-fitting. The final overall model was refined against the overall 3.8 Å map using REFMAC in reciprocal space (Murshudov et al., 1997) , using secondary structure restraints that were generated by ProSMART (Nicholls et al., 2014) . Electron scattering factor was used during refinement in reciprocal space. Overfitting of the overall model was monitored by refining the model in one of the two independent maps from the gold-standard refinement approach, and testing the refined model against the other map (Amunts et al., 2014) ( Figure S4B ). The structures of the human C* complex were also validated through examination of Molprobity scores, statistics of Ramachandran plots (Table  S1 ). Molprobity scores were calculated as described (Davis et al., 2007) .
QUANTIFICATION AND STATISTICAL ANALYSIS
Resolution estimations of cryo-EM density maps are based on the 0.143 Fourier Shell Correlation criterion (Chen et al., 2013; Rosenthal and Henderson, 2003) .
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the atomic coordinates and the EM density map reported in this paper are PDB: 5XJC (http://www.rcsb. org) and EMDB: EMD-6721 (https://www.ebi.ac.uk/pdbe/emdb/), respectively.
